FAISALABAD:Faisalabad Development Authority (FDA) has promoted six employees to their next grades on a regular basis, recognizing their professional performance, services and contributions while advancing the departmental promotion process.
An FDA spokesman said here on Thursday that a formal notification has been issued in accordance with the recommendations of the Departmental Promotion Committee (DPC).
The employees promoted include Manzar Abbas, Draftsman, to Divisional Head Draftsman (BS-15), Muhammad Usman, Junior Accountant, to Accountant (BS-15), Mrs. Alia Hafeez, Junior Computer Operator, to Computer Operator (BS-15); Junaid Ali, Tracer, to Draftsman (BS-14), Babar Hussain, Driver, to Head Driver (BS-11) and Naeem Iqbal, Sanitary Worker, to Sanitary Supervisor (BS-05).
The promotion orders were issued by Additional Director General FDA Qaiser Javed.
The promoted employees met Director General FDA Muhammad Asif Chaudhary and expressed their gratitude to him.
They termed the promotion decision an acknowledgment of their professional services, hard work and commitment to their departmental responsibilities.
Director IT/Deputy Director Administration Yasar Ejaz Chattha and other officers were also present on the occasion.
Congratulating the promoted employees, Director General FDA Muhammad Asif Chaudhary said that the welfare of employees, protection of their legitimate rights and timely departmental promotions were among the key administrative priorities of the Authority.
He said that encouraging employees and providing them with opportunities for professional growth not only improved their individual performance but also enhanced the overall efficiency of the institution and helped ensure better service delivery to the public.
He urged the promoted employees to discharge their new responsibilities with dedication, honesty, a strong sense of duty and professional commitment, while continuing to play an effective role in the institutional improvement and public service mission of the FDA.
He further stated that the FDA administration would continue to take all possible measures to recognize employees’ performance and ensure their timely promotions and the provision of their legitimate rights.